clinical trial

D07 Pridopidine maintenance of total functional capacity (tfc) is associated with stabilization of plasma neurofilament light (NFL) levels
Michal Geva, Deniz Akinc Abdulhayoglu, Noga Gershoni-Emek, Y Paul Goldberg, Bruno Boulanger, Michael R Hayden

Journal of Neurology, Neurosurgery & Psychiatry Sep 2022, 93 (Suppl 1) A22; DOI: 10.1136/jnnp-2022-ehdn.63
F42 Exposure response analysis (PKPD) predicts optimal exposure of pridopidine for clinical efficacy of functional capacity
Michal Geva, Andrew McGarry, Noga Gershoni Emek, Munish Mehra, C Warren Olanow, Karl Kieburtz, Michael R Hayden

Journal of Neurology, Neurosurgery & Psychiatry Sep 2021, 92 (Suppl 1) A36; DOI: 10.1136/jnnp-2021-EHDN.85
F41 The proof-hd phase 3 study: pridopidine’s outcome on function in huntington disease (PROOF)
Ralf Reilmann, Anne Rosser, Sandra Kostyk, Michal Geva, Andrew McGarry, Yael Cohen, Noga Gershoni-Emek, Munish Mehra, C Warren Olanow, Karl Kieburtz, Michael R Hayden, Andrew Feigin

Journal of Neurology, Neurosurgery & Psychiatry Sep 2021, 92 (Suppl 1) A36; DOI: 10.1136/jnnp-2021-EHDN.84
F43 Pridopidine maintenance of total functional capacity (TFC) is associated with stabilization of plasma neurofilament light (NfL) levels
Michal Geva, Deniz Akinc Abdulhayoglu, Noga Gershoni Emek, Y Paul Goldberg, Charles Li, Jennifer Dreymann, Bruno Boulanger, Michael R Hayden

Journal of Neurology, Neurosurgery & Psychiatry Sep 2021, 92 (Suppl 1) A37; DOI: 10.1136/jnnp-2021-EHDN.86
F46 The European huntington’s disease network
Jenny Townhill, Tim McLean, Jamie Levey, Anne Rosser, Patrick Weydt, Michael Orth, Christine Capper-Loup, EHDN Central Coordination

Journal of Neurology, Neurosurgery & Psychiatry Sep 2021, 92 (Suppl 1) A38; DOI: 10.1136/jnnp-2021-EHDN.89
F49 Enroll-HD clinical trial committee
The Enroll-HD Platform Team

Journal of Neurology, Neurosurgery & Psychiatry Sep 2021, 92 (Suppl 1) A39; DOI: 10.1136/jnnp-2021-EHDN.92
F50 Enroll-HD platform support for industry and academic sponsors
The Enroll-HD Platform Team

Journal of Neurology, Neurosurgery & Psychiatry Sep 2021, 92 (Suppl 1) A40; DOI: 10.1136/jnnp-2021-EHDN.93
J01 Triheptanoin is associated with clinical stability and decreased caudate atrophy in huntington disease
Fanny Mochel, Aurélie Meneret, Isaac Adanyeguh, Camille Giron, Elodie Hainque, Marie-Pierre Luton, Marie-Pierre Luton, Mariana Atencio, Milou Jacobs, Fleur Veldkamp, Emma Coppen, Kasper van der Zwaan, Eric Vicaut, Raymund AC Roos, Alexandra Durr

Journal of Neurology, Neurosurgery & Psychiatry Sep 2021, 92 (Suppl 1) A53; DOI: 10.1136/jnnp-2021-EHDN.128
Onset of efficacy and duration of response of galcanezumab for the prevention of episodic migraine: a post-hoc analysis
Peter J Goadsby, David W Dodick, James M Martinez, Margaret B Ferguson, Tina M Oakes, Qi Zhang, Vladimir Skljarevski, Sheena K Aurora

Journal of Neurology, Neurosurgery & Psychiatry Aug 2019, 90 (8) 939-944; DOI: 10.1136/jnnp-2018-320242
Increased deep grey matter functional connectivity of poststroke hNSC implanted ipsilesional putamen
Dheeraj Kalladka, John Sinden, John McLean, Fiona Catherine Moreton, Xuya Huang, Keith W Muir

Journal of Neurology, Neurosurgery & Psychiatry Aug 2019, 90 (8) 959-960; DOI: 10.1136/jnnp-2018-319022

Main menu

clinical trial

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

clinical trial

Pages